← feed

Is NCT05107063 results overdue?

Yes — results are overdue. Primary completion was 2018-04-19; the FDAAA-801 reporting deadline (2019-04-19) passed 2666 days ago and no results are posted on ClinicalTrials.gov.

An Observational Study Investigating the Effectiveness of Pravastatin on Renal Function in Korean Dyslipidemic Patients With Type 2 Diabetes

NCT IDNCT05107063 ↗
SponsorDaiichi Sankyo (INDUSTRY)
Phase
StatusCOMPLETED
Primary completion2018-04-19 (ACTUAL)
Reporting deadline2019-04-19 (completion + 365d)
Days overdue2666
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 b61e5b4fe4e9c96e… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT05107063. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →